We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Petition Calls for Strict Interchangeability Criteria for Biosimilars
Petition Calls for Strict Interchangeability Criteria for Biosimilars
In anticipation of proposed guidance on biosimilar interchangeability, AbbVie is requesting that the FDA hold a hearing to ensure the agency considers all viewpoints.